Physicians' desk reference. 44th ed.Montvale, NJ: Medical Economics, 1990.
2.
KauffmanRE. Remarks to Council on Competitiveness. Washington, DC: American Academy of Pediatrics, October 8, 1991.
3.
MilsapRLHillMRSziflerSJ. Special pharmacokinetic considerations in children. In: EvansWESchentagJJJuskoWJ, eds. Applied pharmacokinetics. 3rd ed.Vancouver, WA: Applied Therapeutics, 1992: 10-1–10-32.
4.
ChayPCWDuffyBJWalkerJS. Pharmacokinetic—pharmacodynamic relationships of morphine in neonates. Clin Pharmacol Ther1992; 51: 334–42.
5.
KatzRKellyHWHsiA. Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Crit Care Med1994; 22: 763–7.
6.
FDA proposes more stringent pediatric-use labeling of prescription drug products. Clin Pharm1993; 12: 6.
7.
BahalOMaraNNahataMC. Teaching in pediatric pharmacotherapy at colleges of pharmacy in the U.S. and Canada. J Clin Pharm Ther1994; 19: 3–6.
